TSN
42
3
CI
63
7
GM
65
-7
HIG
75
4
MRK
35
2
INTU
56
3
OKE
78
3
BWA
48
-5
CME
64
5
AZO
53
3
OI
38
-5
LEG
43
-7
XRX
42
-3
AEP
58
4
COP
47
2
LUV
42
-3
BBY
42
2
HST
59
7
COST
66
3
PYPL
56
-4
TSN
42
3
CI
63
7
GM
65
-7
HIG
75
4
MRK
35
2
INTU
56
3
OKE
78
3
BWA
48
-5
CME
64
5
AZO
53
3
OI
38
-5
LEG
43
-7
XRX
42
-3
AEP
58
4
COP
47
2
LUV
42
-3
BBY
42
2
HST
59
7
COST
66
3
PYPL
56
-4
Financhill
Back

ProShares UltraShort Technology Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
22

REW
ProShares UltraShort Technology

Last Price:
10.46
Seasonality Move:
-12.28%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
138.01
Seasonality Move:
14.88%
Sell
22
ProShares UltraShort Technology (REW) is a Sell

Is ProShares UltraShort Technology a Buy, Sell or Hold?

  • The current ProShares UltraShort Technology [REW] share price is $10.17. The Score for REW is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • REW is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REW Stock Price Chart

What is ProShares UltraShort Technology's stock price today?

  • The ProShares UltraShort Technology share price today is $10.17
    The current trend is relatively stagnant and REW is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

REW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 42.7 Sell
Chaikin Money Flow: -5697 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.1 - 10.86) Sell
Bollinger Bands (100): (10.36 - 12.6) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

REW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.43 Sell
20-day SMA: 10.45 Sell
50-day SMA: 10.71 Sell
200-day SMA: 12.5 Sell
8-day EMA: 10.31 Sell
20-day EMA: 10.42 Sell
50-day EMA: 10.78 Sell
200-day EMA: 13.06 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

ProShares UltraShort Technology Earnings Growth & REW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

ProShares UltraShort Technology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):